Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Anti-Atherosclerotic Activity of N-Hexane Extract of Eleutherine americana Merr. on Human Macrophage Primary Cell Culture

Siti Khotimah, Handono Kalim, Mohammad Saifur Rohman, Setyawati Soeharto.




Abstract
Cited by 0 Articles

Atherosclerosis, a chronic disorder and the main pathogenesis of various cardiovascular diseases, is initiated by the formation of the macrophage foam cell at sub endothelial layer of blood vessel wall. This study aimed to investigate the anti-atherosclerosis activity of n-hexane extract of Eleuherine americana Merr. (E. americana) on human macrophage through in-vitro induction with oxidized LDL (ox-LDL). The macrophage was obtained from peripheral blood mononuclear cells (PBMCs) that were isolated from the serum of healthy male. After the monocytes were maturely differentiated, the n-hexane extract of E. americana with the dose of 0.25, 1 and 2 mg/ml was added before stimulation with ox-LDL. The foam cell was determined through Oil Red O staining, the expressions of Toll-Like Receptor 4 (TLR4) and ATP-binding cassette transporter A1/G1 (ABCA1/ABCG1) were measured by immunofluorescence, and the activity of peroxisome-proliferator-activator receptor γ (PPARγ) was measured through ELISA. The results demonstrated that the foam cell and the expression of TLR4 on the group with E. americana extract treatment were lower than ox-LDL group (p < 0.05). The expression of ABCA1 and ABCG1 on the group that was given the extract was higher than ox-LDL group (p < 0.05). This study concluded that the n-hexane extract of E. americana demonstrated anti-atherosclerosis activity on human macrophage induced with ox-LDL.

Key words: Eleutherine americana Merr., foam cell, TLR4, ABCA1, ABCG1






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.